Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Simulating the outcome of amyloid treatments in Alzheimer’s Disease from multi-modal imaging and clinical data

Clément Abi Nader, Nicholas Ayache, Giovanni B. Frisoni, Philippe Robert, Marco Lorenzi, for the Alzheimer’s Disease Neuroimaging Initiative
doi: https://doi.org/10.1101/2020.09.02.279521
Clément Abi Nader
aUniversité Côte d’Azur, Inria Sophia Antipolis, Epione Research Project, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: clement.abi-nader@inria.fr
Nicholas Ayache
aUniversité Côte d’Azur, Inria Sophia Antipolis, Epione Research Project, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni B. Frisoni
bMemory Clinic and LANVIE-Laboratory of Neuroimaging of Aging, Hospitals and University of Geneva, Geneva, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Philippe Robert
cUniversité Côte d’Azur, CoBTeK lab, MNC3 program, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco Lorenzi
aUniversité Côte d’Azur, Inria Sophia Antipolis, Epione Research Project, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Recent failures of clinical trials in Alzheimer’s Disease underline the critical importance of identifying optimal intervention time to maximize cognitive benefit. While several models of disease progression have been proposed, we still lack quantitative approaches simulating the effect of treatment strategies on the clinical evolution. In this work, we present a data-driven method to model dynamical relationships between imaging and clinical biomarkers. Our approach allows simulating intervention at any stage of the pathology by modulating the progression speed of the biomarkers, and by subsequently assessing the impact on disease evolution. When applied to multi-modal imaging and clinical data from the Alzheimer’s Disease Neuroimaging Initiative our method enables to generate hypothetical scenarios of amyloid lowering interventions. Our results show that in a study with 1000 individuals per arm, accumulation should be completely arrested at least 5 years before Alzheimer’s dementia diagnosis to lead to statistically powered improvement of clinical endpoints.

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • ↵1 Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted October 23, 2020.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Simulating the outcome of amyloid treatments in Alzheimer’s Disease from multi-modal imaging and clinical data
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Simulating the outcome of amyloid treatments in Alzheimer’s Disease from multi-modal imaging and clinical data
Clément Abi Nader, Nicholas Ayache, Giovanni B. Frisoni, Philippe Robert, Marco Lorenzi, for the Alzheimer’s Disease Neuroimaging Initiative
bioRxiv 2020.09.02.279521; doi: https://doi.org/10.1101/2020.09.02.279521
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Simulating the outcome of amyloid treatments in Alzheimer’s Disease from multi-modal imaging and clinical data
Clément Abi Nader, Nicholas Ayache, Giovanni B. Frisoni, Philippe Robert, Marco Lorenzi, for the Alzheimer’s Disease Neuroimaging Initiative
bioRxiv 2020.09.02.279521; doi: https://doi.org/10.1101/2020.09.02.279521

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Bioinformatics
Subject Areas
All Articles
  • Animal Behavior and Cognition (2433)
  • Biochemistry (4793)
  • Bioengineering (3334)
  • Bioinformatics (14695)
  • Biophysics (6644)
  • Cancer Biology (5176)
  • Cell Biology (7436)
  • Clinical Trials (138)
  • Developmental Biology (4372)
  • Ecology (6881)
  • Epidemiology (2057)
  • Evolutionary Biology (9930)
  • Genetics (7349)
  • Genomics (9535)
  • Immunology (4567)
  • Microbiology (12698)
  • Molecular Biology (4952)
  • Neuroscience (28366)
  • Paleontology (199)
  • Pathology (809)
  • Pharmacology and Toxicology (1393)
  • Physiology (2025)
  • Plant Biology (4509)
  • Scientific Communication and Education (978)
  • Synthetic Biology (1302)
  • Systems Biology (3917)
  • Zoology (728)